Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

232 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Dose-response with stereotactic body radiotherapy for prostate cancer: A multi-institutional analysis of prostate-specific antigen kinetics and biochemical control.
Levin-Epstein RG, Jiang NY, Wang X, Upadhyaya SK, Collins SP, Suy S, Aghdam N, Mantz C, Katz AJ, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas N, Bagshaw H, Buyyounouski MK, Cao M, Agazaryan N, Dang A, Yuan Y, Kupelian PA, Zaorsky NG, Spratt DE, Mohamad O, Feng FY, Mahal BA, Boutros PC, Kishan AU, Juarez J, Shabsovich D, Jiang T, Kahlon S, Patel A, Patel J, Nickols NG, Steinberg ML, Fuller DB, Kishan AU. Levin-Epstein RG, et al. Among authors: katz aj. Radiother Oncol. 2021 Jan;154:207-213. doi: 10.1016/j.radonc.2020.09.053. Epub 2020 Oct 7. Radiother Oncol. 2021. PMID: 33035622 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 34701090
Four-year Prostate-specific Antigen Response Rate as a Predictive Measure in Intermediate-risk Prostate Cancer Treated With Ablative Therapies: The SPRAT Analysis.
Glicksman RM, Kishan AU, Katz AJ, Mantz CA, Collins SP, Fuller DB, Steinberg ML, Shabsovich D, Zhang L, Loblaw A. Glicksman RM, et al. Among authors: katz aj. Clin Oncol (R Coll Radiol). 2022 Jan;34(1):36-41. doi: 10.1016/j.clon.2021.11.004. Epub 2021 Nov 24. Clin Oncol (R Coll Radiol). 2022. PMID: 34836735
Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series.
Juarez JE, Romero T, Mantz CA, Pepin A, Aghdam N, Suy S, Steinberg ML, Levin-Epstein RG, Nickols NG, Kaplan ID, Meier RM, Pham HT, Linson PW, Hong RL, Buyyounouski MK, Bagshaw HP, Fuller DB, Katz AJ, Loblaw A, Collins SP, Kishan AU. Juarez JE, et al. Among authors: katz aj. Adv Radiat Oncol. 2021 Aug 28;6(6):100759. doi: 10.1016/j.adro.2021.100759. eCollection 2021 Nov-Dec. Adv Radiat Oncol. 2021. PMID: 34585025 Free PMC article.
Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.
Kishan AU, Dang A, Katz AJ, Mantz CA, Collins SP, Aghdam N, Chu FI, Kaplan ID, Appelbaum L, Fuller DB, Meier RM, Loblaw DA, Cheung P, Pham HT, Shaverdian N, Jiang N, Yuan Y, Bagshaw H, Prionas N, Buyyounouski MK, Spratt DE, Linson PW, Hong RL, Nickols NG, Steinberg ML, Kupelian PA, King CR. Kishan AU, et al. Among authors: katz aj. JAMA Netw Open. 2019 Feb 1;2(2):e188006. doi: 10.1001/jamanetworkopen.2018.8006. JAMA Netw Open. 2019. PMID: 30735235 Free PMC article.
Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.
Levin-Epstein R, Cook RR, Wong JK, Stock RG, Jeffrey Demanes D, Collins SP, Aghdam N, Suy S, Mantz C, Katz AJ, Nickols NG, Miszczyk L, Napieralska A, Namysl-Kaletka A, Prionas ND, Bagshaw H, Buyyounouski MK, Cao M, Mahal BA, Shabsovich D, Dang A, Yuan Y, Rettig MB, Chang AJ, Jackson WC, Spratt DE, Lehrer EJ, Zaorsky NG, Kupelian PA, Steinberg ML, Horwitz EM, Jiang NY, Kishan AU. Levin-Epstein R, et al. Among authors: katz aj. Radiother Oncol. 2020 Oct;151:26-32. doi: 10.1016/j.radonc.2020.07.014. Epub 2020 Jul 11. Radiother Oncol. 2020. PMID: 32663537
Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
van Dams R, Jiang NY, Fuller DB, Loblaw A, Jiang T, Katz AJ, Collins SP, Aghdam N, Suy S, Stephans KL, Yuan Y, Nickols NG, Murthy V, Telkhade TP, Kupelian PA, Steinberg ML, Romero T, Kishan AU. van Dams R, et al. Among authors: katz aj. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):731-737. doi: 10.1016/j.ijrobp.2021.01.016. Epub 2021 Jan 23. Int J Radiat Oncol Biol Phys. 2021. PMID: 33493615 Free PMC article. Clinical Trial.
[No title available]
[No authors listed] [No authors listed] PMID: 34701066
232 results